These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 990786)

  • 1. Two cases of ethambutol nephrotoxicity.
    Collier J; Joekes AM; Philalithis PE; Thompson FD
    Br Med J; 1976 Nov; 2(6044):1105-6. PubMed ID: 990786
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 4. [New anti-tubercular agents--rifampicin and ethambutol].
    El'nik VI
    Klin Med (Mosk); 1971 May; 49(5):8-11. PubMed ID: 4946528
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin.
    Jenne JW; Beggs WH
    Am Rev Respir Dis; 1973 Jun; 107(6):1013-21. PubMed ID: 4197230
    [No Abstract]   [Full Text] [Related]  

  • 6. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 7. [Importance of early performance of the Farnsworth test in the course of anti-tubercular therapy with ethambutol].
    Minutillo U; Severino R; Erpici M; Pezza A; Cotticelli L; Peccarino V
    Arch Monaldi; 1979; 34(1-2):70-82. PubMed ID: 554577
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ocular toxicity of ethambutol].
    Hermann P
    Annee Ther Clin Ophtalmol; 1971; 22():387-93. PubMed ID: 4127784
    [No Abstract]   [Full Text] [Related]  

  • 9. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
    Lesobre R; Frey N
    Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proceedings: Rifampicin in initial therapy of pulmonary tuberculosis].
    Gyselen A; Cosemans J; Lacquet L; Verbist L
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):128-35. PubMed ID: 4491709
    [No Abstract]   [Full Text] [Related]  

  • 11. [Two cases of pulmonary tuberculosis having evolved after the first attack with triple therapy of isoniazid, rifampicin and ethambutol].
    Wipf R
    Rev Med Suisse Romande; 1979 Apr; 99(4):205-13. PubMed ID: 504855
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of rifampin and ethambutol for the treatment of pulmonary tuberculosis].
    Shukiurov ShZ
    Probl Tuberk; 1973; 51(12):40-3. PubMed ID: 4782102
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative trial with combinations of rifampicin, ethambutol and isoniazid (Hydronsan) in previously untreated cases of pulmonary tuberculosis.
    Dormer BA; Salinger PL
    S Afr Med J; 1971 Jun; 45(25):697-9. PubMed ID: 5559403
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of the chemotherapy of tuberculosis. Part II.
    Lauver GL
    Ariz Med; 1978 Mar; 35(3):163-5. PubMed ID: 637730
    [No Abstract]   [Full Text] [Related]  

  • 16. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
    Zierski M
    Scand J Respir Dis Suppl; 1978; 102():48-52. PubMed ID: 278215
    [No Abstract]   [Full Text] [Related]  

  • 18. Light-chain proteinuria and reversible renal failure in rifampin-treated patients with tuberculosis.
    Kumar S; Mehta JA; Trivedi HL
    Chest; 1976 Oct; 70(4):564-5. PubMed ID: 824103
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.